	US 11,867,697 B2
	Pancreatic cancer detection method and pancreatic cancer detection kit
Makoto Itonaga, Yokohama (JP); Masayuki Ono, Yokosuka (JP); Takahiro Yokose, Tokyo (JP); Atsushi Matsuda, Tokyo (JP); Yasuaki Kabe, Tokyo (JP); Sachiko Matsuda, Tokyo (JP); Miwa Hirai, Tokyo (JP); and Minoru Kitago, Tokyo (JP)
Assigned to JVCKENWOOD CORPORATION, Yokohama (JP); and KEIO UNIVERSITY, Tokyo (JP)
Filed by JVCKENWOOD Corporation, Yokohama (JP); and KEIO UNIVERSITY, Tokyo (JP)
Filed on Aug. 17, 2021, as Appl. No. 17/404,717.
Claims priority of application No. 2020-147108 (JP), filed on Sep. 1, 2020.
Prior Publication US 2022/0065858 A1, Mar. 3, 2022
Int. Cl. G01N 33/574 (2006.01)

CPC G01N 33/5748 (2013.01) [G01N 33/57438 (2013.01)]

10 Claims

1. A pancreatic cancer detection method comprising:

(a) bringing extracellular vesicles, which are in a body fluid sample derived from a subject, into contact with one or more kinds of lectins;

(b) measuring an amount of the extracellular vesicles bound to the one or more kinds of lectins after (a); and

(c) evaluating presence of pancreatic cancer in the subject based on the amount of the extracellular vesicles measured in (b),

wherein the evaluation of the presence of the pancreatic cancer is applied in treating the pancreatic cancer in the subject having pancreatic cancer who is identified in (c).